GSK to Cut up to 1,217 Jobs in Belgium, L’Echo Says
The company said the plan could affect up to 1,217 employees as it reorganizes certain operations, while factory workers remain exempt.
- On Wednesday, British biopharmaceutical company GSK announced plans to cut up to 1,217 jobs across its Belgium locations, specifically excluding factory workers from the reorganization.
- These layoffs are part of a $2.5 billion global restructuring plan spanning three years to reallocate capital toward late-stage R&D, following GSK's recent closure of a German manufacturing facility affecting about 650 roles.
- Reductions will occur at GSK Belgium sites in Rixensart, Wavre, and Gembloux, though the company noted it remains Belgium's largest biopharma employer with operations contributing over 50% of global vaccine production.
- GSK's vaccine business remains strong, with second-quarter sales growing 8% year-on-year, driven by Shingrix generating $1.2 billion and Arexvy surging more than 100% to $270 million.
- Streamlining research, manufacturing, and support operations via digital and automation tools is the company's stated goal, though GSK has not yet specified which exact roles will be impacted.
29 Articles
29 Articles
BRITISH GSK is cutting up to 1,217 jobs in Belgium as part of a €2.2 billion cost-savings plan to speed up the development of innovative medicines.
Its subsidiary GSK Belgium, which has more than 8,000 employees, is one of the largest private employers in Wallonia, deployed on three sites in this French-speaking region. The restructuring, announced on Wednesday morning at an extraordinary works council, is therefore about 15% of the workforce. "The aim is to align the organisation and industrial capacities with the structural evolution of global demand for certain vaccines", the subsidiary …
In Belgium, the pharmaceutical company has more than 8,000 employees, and the restructuring could cover around 15% of the staff.
Last July, the group Gsk, quoted on the London Stock Exchange, announced a net profit in decrease of more than two thirds in the second trimester, result weighted by the interruption of the development of a drug for the chronic cough
GSK plans to cut up to 1,217 jobs in its units in Belgium, informed the British pharmaceutical company. The plan was formally communicated to the unions on Wednesday, according to the Belgian newspaper L-Echo. The unions did not immediately respond to requests for comment. Despite the cuts, the multinational company highlighted that it will continue to be the largest employer of the biopharmaceutical sector in Belgium. -GSK Belgium informed its …
Coverage Details
Bias Distribution
- 42% of the sources are Center, 42% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
